Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intriguing findings of liver fibrosis following COVID-19.
Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Kolesova O, et al. Among authors: derovs a. BMC Gastroenterol. 2021 Oct 11;21(1):370. doi: 10.1186/s12876-021-01939-7. BMC Gastroenterol. 2021. PMID: 34635073 Free PMC article.
Gut colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae may increase disease activity in biologic-naive outpatients with ulcerative colitis: an interim analysis.
Skuja V, Derovs A, Pekarska K, Rudzite D, Lavrinovica E, Piekuse L, Kempa I, Straume Z, Eglite J, Lejnieks A, Krumina A, Eliakim R. Skuja V, et al. Among authors: derovs a. Eur J Gastroenterol Hepatol. 2018 Jan;30(1):92-100. doi: 10.1097/MEG.0000000000000989. Eur J Gastroenterol Hepatol. 2018. PMID: 29076938
THINK PORPHYRIA: CASE REPORT AND REVIEW OF LITERATURE.
Straume Z, Skuja V, Proskurina A, Māliņa J, Hasnere S, Krupnova I, Lejnieks A, Derovs A. Straume Z, et al. Among authors: derovs a. Eksp Klin Gastroenterol. 2015;(7):69-77. Eksp Klin Gastroenterol. 2015. PMID: 26817125 Review. English, Russian.
Replication study of ulcerative colitis risk loci in a Lithuanian-Latvian case-control sample.
Skieceviciene J, Kiudelis G, Ellinghaus E, Balschun T, Jonaitis LV, Zvirbliene A, Denapiene G, Leja M, Pranculiene G, Kalibatas V, Saadati H, Ellinghaus D, Andersen V, Valantinas J, Irnius A, Derovs A, Tamelis A, Schreiber S, Kupcinskas L, Franke A. Skieceviciene J, et al. Among authors: derovs a. Inflamm Bowel Dis. 2013 Oct;19(11):2349-55. doi: 10.1097/MIB.0b013e3182a3eaeb. Inflamm Bowel Dis. 2013. PMID: 23974994
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.
Dignass A, Stoynov S, Dorofeyev AE, Grigorieva GA, Tomsová E, Altorjay I, Tuculanu D, Bunganič I, Pokrotnieks J, Kupčinskas L, Dilger K, Greinwald R, Mueller R; International Budenofalk Study Group. Dignass A, et al. J Crohns Colitis. 2014 Sep;8(9):970-80. doi: 10.1016/j.crohns.2014.01.021. Epub 2014 Feb 15. J Crohns Colitis. 2014. PMID: 24534142 Clinical Trial.
13 results